VIDAZA Powder for suspension for injection (2019)
Active ingredients: Azacitidine
Product Name and Form
Vidaza 25 mg/mL powder for suspension for injection.
Powder for suspension for injection.
White lyophilised powder.
Qualitative and Quantitative Composition
Each vial contains 100 mg azacitidine. After reconstitution, each mL of suspension contains 25 mg azacitidine.
For the full list of excipients, see section 6.1.
Pack sizes and Marketing
Colourless type I glass vial sealed with butyl elastomeric stopper and aluminium seal with polypropylene plastic button, containing 100 mg of azacitidine.
Pack size: 1 vial.
Celgene Europe B.V., Winthontlaan 6 N, 3526 KV Utrecht, Netherlands
Date of first authorisation: 17 December 2008
Date of latest renewal: 13 November 2013